Silk Road Medical (SILK)
(Delayed Data from NSDQ)
$27.09 USD
+0.03 (0.11%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $27.08 -0.01 (-0.04%) 6:26 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SILK 27.09 +0.03(0.11%)
Will SILK be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SILK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SILK
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
Strength Seen in Silk Road Medical (SILK): Can Its 24.0% Jump Turn into More Strength?
SILK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
Other News for SILK
3 Record-Breaking Stocks With More Room to Run
SILK Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Silk Road Medical to Boston Scientific
Futures Flat As Tech Stocks Rise For 7th Consecutive Day
Boston Scientific Acquires Silk Road Medical: Unveiling Investor Implications
12 Health Care Stocks Moving In Wednesday's Intraday Session